ARTICLE | Politics, Policy & Law
PDUFA VII to feature $4M fee, focus on cell, gene therapies
Funding increases for CBER as FDA expects onslaught of applications for new modality therapies
March 12, 2021 9:32 PM UTC
FDA and biopharma industry representatives have agreed on most elements of the next Prescription Drug User Fee Act deal, including an increase in the application fee to about $4 million by 2027 from ...
BCIQ Company Profiles